Halogenated 4-(Phenoxymethyl)piperidines as Potential Radiolabeled Probes for σ-1 Receptors:  In Vivo Evaluation of [123I]-1-(Iodopropen-2-yl)-4-[(4-cyanophenoxy)methyl]piperidine

Several halogenated 4-(4-phenoxymethyl)piperidines were synthesized as potential σ receptor ligands. The affinity and selectivity of these compounds were determined using in vitro receptor binding assays, and their log P values were estimated using HPLC analysis. The effect of various N-substituents...

Full description

Saved in:
Bibliographic Details
Published inJournal of medicinal chemistry Vol. 40; no. 11; pp. 1657 - 1667
Main Authors Waterhouse, Rikki N, Mardon, Karine, Giles, Katrina M, Collier, T. Lee, O'Brien, Joanne C
Format Journal Article
LanguageEnglish
Published WASHINGTON American Chemical Society 23.05.1997
Amer Chemical Soc
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Several halogenated 4-(4-phenoxymethyl)piperidines were synthesized as potential σ receptor ligands. The affinity and selectivity of these compounds were determined using in vitro receptor binding assays, and their log P values were estimated using HPLC analysis. The effect of various N-substituents on the σ-1 and σ-2 dissociation constants was examined. These substituents included fluoroalkyl, hydroxyalkyl, iodopropenyl, and selected ortho-, meta-, and para-substituted benzyl groups. Also determined were the effects of various moieties on the phenoxy ring; specifically 4-iodo, 4-bromo, 4-nitro, 4-cyano, 3-bromo, and pentafluoro substituents were examined. The ranges in the dissociation constants of these compounds for σ-1 and σ-2 receptors were 0.38−24.3 and 3.9−361 nM, respectively. The ratio of K i (σ-2/σ-1) ranged from 1.19 to 121. One of the most promising of the iodinated ligands, 1-(trans-iodopropen-2-yl)-4-[(4-cyanophenoxy)methyl]piperidine (4), was labeled with 123I and studied in vivo in adult male rats. High uptake and good retention of radioactivity was observed in the brain and many other organs known to possess σ receptors. Blocking studies revealed high specific binding of [123I]-4 to σ receptors in the brain, lung, kidney, heart, muscle, and other organs known to possess these sites. These results indicate that [123I]-4 and other halogenated 4-(phenoxymethyl)piperidines of this series may provide useful probes for in vivo tomographic studies of σ receptors.
Bibliography:Abstract published in Advance ACS Abstracts, April 15, 1997.
istex:AB767E1714ABF4C6F01FC7614D3603623C52FA03
ark:/67375/TPS-0NSCXCVS-Z
Medline
NIH RePORTER
ISSN:0022-2623
1520-4804
DOI:10.1021/jm960720+